LDR | |
00951nam a22002771i 4500 |
001 |
|
000242527 |
003 |
|
MiAaHDL |
005 |
|
20210817000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
880718s1979 enka b 00110 eng d |
010 |
⊔ |
⊔ |
‡a79042886
|
020 |
⊔ |
⊔ |
‡a0080255108
|
035 |
⊔ |
⊔ |
‡a(MiU)990002425270106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990002425270106381
|
035 |
⊔ |
⊔ |
‡asdr-nrlfGLAD151280442-B
|
035 |
⊔ |
⊔ |
‡a(OCoLC)5999280
|
035 |
⊔ |
⊔ |
‡a(CaOTULAS)160401301
|
035 |
⊔ |
⊔ |
‡a(RLIN)MIUG84-B19628
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph000242527
|
040 |
⊔ |
⊔ |
‡aCtY
‡cCtY
‡dIaU
|
100 |
1 |
⊔ |
‡aUsdin, Earl.
|
245 |
1 |
0 |
‡aPsychotropic drugs and related compounds /
‡cEarl Usdin and Daniel H. Efron.
|
250 |
⊔ |
⊔ |
‡a2d ed.
|
260 |
⊔ |
⊔ |
‡aOxford ;
‡aNew York :
‡bPergamon Press,
‡c1979.
|
300 |
⊔ |
⊔ |
‡avi, 791 p. :
‡bill. ;
‡c26 cm.
|
500 |
⊔ |
⊔ |
‡aReprint of the 1972 ed. published by the National Institute of Mental Health, Rockville, Md.
|
504 |
⊔ |
⊔ |
‡aBibliography: p. 605-657.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aPsychotropic drugs
|
700 |
1 |
⊔ |
‡aEfron, Daniel H.
‡ejoint author.
|
710 |
2 |
⊔ |
‡aNational Institute of Mental Health (U.S.)
|
CID |
⊔ |
⊔ |
‡a000242527
|
DAT |
0 |
⊔ |
‡a19880718000000.0
‡b20210817000000.0
|
DAT |
1 |
⊔ |
‡a20210827091056.0
‡b2023-11-16T18:31:28Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990002425270106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015006009636
‡sMIU
‡1990002425270106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20231116
‡sgoogle
‡umdp.39015006009636
‡y1979
‡ric
‡qbib
‡tnon-US bib date1 >= 1929
|
974 |
⊔ |
⊔ |
‡bUC
‡cNRLF
‡d20231117
‡sgoogle
‡uuc1.b4169916
‡y1979
‡ric
‡qbib
‡tnon-US bib date1 >= 1929
|